Case Report Concerning a Varicella Zoster Virus Infection in a Six-year-old Child Receiving Dupilumab for Atopic Dermatitis
DOI:
https://doi.org/10.2340/actadv.v106.adv-2025-0045Keywords:
eczema, dupilumab, VZV, vaccineDownloads
References
Paller AS, Beck LA, Blauvelt A, Siegfried EC, Cork MJ, Wollenberg A, et al. Infections in children and adolescents treated with dupilumab in pediatric clinical trials for atopic dermatitis-A pooled analysis of trial data. Pediatr Dermatol 2022; 39: 187–196. DOI: https://doi.org/10.1111/pde.14909
Rimmer S, Culotta N, Hill I. Disseminated varicella zoster virus and herpes zoster virus infection in a pediatric patient with atopic dermatitis. Pract Dermatol 2024; 14: 29–31.
Eichenfield LF, Bieber T, Beck LA, Simpson EL, Thaçi D, de Bruin-Weller M, et al. Infections in dupilumab clinical trials in atopic dermatitis: a comprehensive pooled analysis. Am J Clin Dermatol 2019; 20: 443–456. DOI: https://doi.org/10.1007/s40257-019-00445-7
Siegfried EC, Wine Lee L, Spergel JM, Prescilla R, Uppal S, Coleman A, et al. A case series of live attenuated vaccine administration in dupilumab-treated children with atopic dermatitis. Pediatr Dermatol 2024; 41: 204–209. DOI: https://doi.org/10.1111/pde.15518
Published
How to Cite
License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All digitalized ActaDV contents is available freely online. The Society for Publication of Acta Dermato-Venereologica owns the copyright for all material published until volume 88 (2008) and as from volume 89 (2009) the journal has been published fully Open Access, meaning the authors retain copyright to their work.
Unless otherwise specified, all Open Access articles are published under CC-BY-NC licences, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material for non-commercial purposes, provided proper attribution to the original work.
